La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Medpace Holdings Croissance future
Future contrôle des critères 3/6
Medpace Holdings devrait augmenter ses bénéfices et son chiffre d'affaires de 13.6% et de 12.6% par an respectivement. Le BPA devrait croître de de 13% par an. Le rendement des capitaux propres devrait être 30.2% dans 3 ans.
Informations clés
13.6%
Taux de croissance des bénéfices
13.0%
Taux de croissance du BPA
Life Sciences croissance des bénéfices | 18.0% |
Taux de croissance des recettes | 12.6% |
Rendement futur des capitaux propres | 30.2% |
Couverture par les analystes | Good |
Dernière mise à jour | 01 Aug 2024 |
Mises à jour récentes de la croissance future
Recent updates
Medpace: Continued Business Growth With Asymmetrical Payoff Opportunity
Aug 20Why Medpace Holdings' (NASDAQ:MEDP) Earnings Are Better Than They Seem
Jul 31Medpace Holdings, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Jul 25What You Can Learn From Medpace Holdings, Inc.'s (NASDAQ:MEDP) P/E
Jun 18Medpace: Clear Winner If China Blockade Succeeds
Jun 04A Look At The Fair Value Of Medpace Holdings, Inc. (NASDAQ:MEDP)
May 22Does Medpace Holdings (NASDAQ:MEDP) Deserve A Spot On Your Watchlist?
Apr 12Medpace: Exceptional Performance, Almost Fully Priced In
Mar 11Medpace Holdings, Inc.'s (NASDAQ:MEDP) 32% Jump Shows Its Popularity With Investors
Feb 18Should You Think About Buying Medpace Holdings, Inc. (NASDAQ:MEDP) Now?
Feb 09A Look At The Intrinsic Value Of Medpace Holdings, Inc. (NASDAQ:MEDP)
Jan 25Should You Be Adding Medpace Holdings (NASDAQ:MEDP) To Your Watchlist Today?
Jan 10Shareholders Should Be Pleased With Medpace Holdings, Inc.'s (NASDAQ:MEDP) Price
Dec 26Should You Investigate Medpace Holdings, Inc. (NASDAQ:MEDP) At US$275?
Nov 08Medpace Holdings, Inc. (NASDAQ:MEDP) Shares Could Be 29% Below Their Intrinsic Value Estimate
Oct 23If EPS Growth Is Important To You, Medpace Holdings (NASDAQ:MEDP) Presents An Opportunity
Oct 10Does Medpace Holdings (NASDAQ:MEDP) Have A Healthy Balance Sheet?
Aug 27Should You Think About Buying Medpace Holdings, Inc. (NASDAQ:MEDP) Now?
Jul 31A Look At The Fair Value Of Medpace Holdings, Inc. (NASDAQ:MEDP)
Jul 18Here's Why We Think Medpace Holdings (NASDAQ:MEDP) Might Deserve Your Attention Today
Jul 04Is Medpace Holdings (NASDAQ:MEDP) A Risky Investment?
May 25Is Now The Time To Look At Buying Medpace Holdings, Inc. (NASDAQ:MEDP)?
Apr 27An Intrinsic Calculation For Medpace Holdings, Inc. (NASDAQ:MEDP) Suggests It's 28% Undervalued
Apr 12We Ran A Stock Scan For Earnings Growth And Medpace Holdings (NASDAQ:MEDP) Passed With Ease
Mar 27Does Medpace Holdings (NASDAQ:MEDP) Have A Healthy Balance Sheet?
Feb 14What Is Medpace Holdings, Inc.'s (NASDAQ:MEDP) Share Price Doing?
Jan 16Medpace Holdings, Inc. (NASDAQ:MEDP) Shares Could Be 41% Below Their Intrinsic Value Estimate
Jan 03Here's Why We Think Medpace Holdings (NASDAQ:MEDP) Might Deserve Your Attention Today
Dec 20Medpace Holdings (NASDAQ:MEDP) Has A Rock Solid Balance Sheet
Nov 16Growth Investors: Industry Analysts Just Upgraded Their Medpace Holdings, Inc. (NASDAQ:MEDP) Revenue Forecasts By 13%
Nov 03Why Medpace Holdings, Inc. (NASDAQ:MEDP) Could Be Worth Watching
Oct 10Medpace Holdings, Inc. (NASDAQ:MEDP) Shares Could Be 33% Below Their Intrinsic Value Estimate
Sep 26Prévisions de croissance des bénéfices et des revenus
Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
---|---|---|---|---|---|
12/31/2026 | 2,776 | 487 | 587 | 635 | 9 |
12/31/2025 | 2,418 | 420 | 514 | 559 | 11 |
12/31/2024 | 2,141 | 372 | 433 | 472 | 11 |
6/30/2024 | 2,030 | 340 | 503 | 540 | N/A |
3/31/2024 | 1,963 | 312 | 473 | 506 | N/A |
12/31/2023 | 1,886 | 283 | 397 | 433 | N/A |
9/30/2023 | 1,782 | 273 | 378 | 414 | N/A |
6/30/2023 | 1,673 | 268 | 373 | 408 | N/A |
3/31/2023 | 1,563 | 257 | 385 | 422 | N/A |
12/31/2022 | 1,460 | 245 | 351 | 388 | N/A |
9/30/2022 | 1,374 | 227 | 286 | 322 | N/A |
6/30/2022 | 1,286 | 209 | 250 | 286 | N/A |
3/31/2022 | 1,213 | 199 | 221 | 252 | N/A |
12/31/2021 | 1,142 | 181 | 235 | 263 | N/A |
9/30/2021 | 1,094 | 182 | 271 | 298 | N/A |
6/30/2021 | 1,028 | 175 | 256 | 285 | N/A |
3/31/2021 | 955 | 159 | 235 | 267 | N/A |
12/31/2020 | 926 | 145 | 227 | 259 | N/A |
9/30/2020 | 896 | 124 | 181 | 210 | N/A |
6/30/2020 | 882 | 107 | 188 | 215 | N/A |
3/31/2020 | 891 | 110 | 196 | 217 | N/A |
12/31/2019 | 861 | 100 | 184 | 202 | N/A |
9/30/2019 | 823 | 93 | 169 | 184 | N/A |
6/30/2019 | 786 | 88 | 160 | 173 | N/A |
3/31/2019 | 742 | 78 | 153 | 167 | N/A |
12/31/2018 | 705 | 73 | 141 | 157 | N/A |
9/30/2018 | 612 | 61 | 130 | 146 | N/A |
6/30/2018 | 531 | 52 | 117 | 132 | N/A |
3/31/2018 | 456 | 45 | N/A | 121 | N/A |
12/31/2017 | 386 | 39 | N/A | 97 | N/A |
9/30/2017 | 382 | 28 | N/A | 98 | N/A |
6/30/2017 | 379 | 23 | N/A | 101 | N/A |
3/31/2017 | 377 | 18 | N/A | 78 | N/A |
12/31/2016 | 371 | 13 | N/A | 92 | N/A |
9/30/2016 | 361 | 5 | N/A | 91 | N/A |
6/30/2016 | 348 | 0 | N/A | 80 | N/A |
3/31/2016 | 332 | -5 | N/A | 94 | N/A |
12/31/2015 | 320 | -9 | N/A | 86 | N/A |
12/31/2014 | 290 | -16 | N/A | 75 | N/A |
12/31/2013 | 244 | 25 | N/A | 98 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de MEDP ( 13.6% par an) est supérieure au taux d'épargne ( 2.5% ).
Bénéfices vs marché: Les bénéfices de MEDP ( 13.6% par an) devraient croître plus lentement que le marché US ( 15.2% par an).
Croissance élevée des bénéfices: Les bénéfices de MEDP devraient augmenter, mais pas de manière significative.
Chiffre d'affaires vs marché: Le chiffre d'affaires de MEDP ( 12.6% par an) devrait croître plus rapidement que le marché US ( 8.8% par an).
Croissance élevée des revenus: Le chiffre d'affaires de MEDP ( 12.6% par an) devrait croître plus lentement que 20% par an.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Le retour sur capitaux propres de MEDP devrait être élevé dans 3 ans ( 30.2 %)